This morning, Johnson & Johnson shared its second-quarter performance.
Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.
“Our solid second-quarter results can be attributed to the dedication and hard work of our Johnson & Johnson colleagues around the world, who perpetually strive to bring differentiated healthcare solutions to the most pressing unmet medical needs,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “As we remain focused on delivering value to all of our stakeholders, we will continue to optimize our portfolio to ensure we make progress against our long-term strategies. Our results during the first half of this year reaffirm our confidence in our 2019 outlook, and position us well to invest for continued success in the future.”
For more details about the company’s second-quarter 2019 results, and to read a comment from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.
Johnson & Johnson’s 2019 2nd-Quarter Earnings
You are now leaving jnj.com
The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Want to see more company earnings information? Find several years of Johnson & Johnson’s quarterly and full-year results here.
